Inactive Instrument

News Avalanche Biotechnologies Inc Nasdaq

Equities

US05337G1076

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Adverum Biotechnologies Files $200 Million Mixed Shelf	Mar. 21	MT
RBC Cuts Price Target on Adverum Biotechnologies to $2 From $3, Keeps Sector Perform, Speculative Risk	Mar. 19	MT
Adverum Biotechnologies: Q4 Earnings Snapshot	Mar. 18	AQ
Adverum Biotechnologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
Adverum Biotechnologies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 18	CI
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates	Mar. 18	AQ
Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference	Feb. 28	AQ
Adverum Biotechnologies, Inc. announced that it has received $127.5 million in funding from a group of investors	Feb. 20	CI
Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 12	AQ
Transcript : Adverum Biotechnologies, Inc. - Special Call	Feb. 08
Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD	Feb. 08	AQ
Adverum Biotechnologies, Inc. Announces Positive Preliminary Efficacy and Safety Data from Luna Phase 2 Trial of Ixo-Cov in Patients with Wet AMD	Feb. 08	CI
4D Molecular soars as mid-stage data for eye disease therapy 'checks all boxes'	Feb. 05	RE
Adverum Biotechnologies Announces $127.5 Million Private Placement Financing	Feb. 05	AQ
Adverum Biotechnologies, Inc. announced that it expects to receive $127.5 million in funding from a group of investors	Feb. 04	CI
Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024	Feb. 01	AQ
Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer	Jan. 29	AQ
Adverum Biotechnologies, Inc. Appoints Romuald Corbau as Chief Scientific Officer and Member of Executive Committee	Jan. 29	CI
Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meeting of the Macula Society	Dec. 07	AQ
Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx Conference	Nov. 28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Avalanche Biotechnologies Inc Nasdaq

Equities

US05337G1076

Summary

Filters